Early Alzheimer’s Detection Test Brings Cure One Step Closer

Israeli expatriate biomedical engineers Eliav Shaked and Roy Kirshon may be far from old age but one of its dreaded curses — Alzheimer’s disease (AD) — figures prominently in their lives. As business partners in an artificial intelligence medical imaging start-up in Toronto called RetiSpec, they’ve developed a new way for early detection of AD, the main cause of dementia among older adults.

In recent years, the World Health Organization has signaled the growing scourge of dementia (attributed mostly to AD) as a global epidemic. Tied, in part, to an aging population, an estimated 47 million people around the world now suffer from AD or related dementia.

“The problem today is the point at which you diagnose Alzheimer’s,” Shaked, 37, told The Times of Israel during a recent interview with him and Kirshon at a Toronto outdoor cafe. “By then, there’s already a neurodegenerative process that’s affecting the way the person thinks and reasons, which is caused by a pathological change in the brain that started 10 or 20 years before those clinical symptoms.”

Read more at Times of Israel.

{Matzav.com}